Autopsy report · NCT02679248

A Study to Investigate the Effect of a Nitric Oxide Supplementation on Pre- and Mildly Hypertensive Adults

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“Slow recruitment”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 1 year 1 month before it stopped.
67 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: KGK Science Inc.
Sponsor type: Industry
Conditions: Pre-hypertension
Interventions: Neo40 Daily®; Placebo
Participants: 67
Sites: 2
Countries: Canada

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.